Belgian Central Sleep Apnea REgistry
ConditionCentral Sleep Apnea
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven
About this trial
This study evaluates different factors that determine the treatment choice and treatment compliance in patients with central sleep apnea. All patients will receive routine care (registry).
Eligibility criteria
Qualifiers
Age ≥ 18 years old
An apnea/hypopnea index ≥ 15/h of sleep and proportion of non-obstructive events > 50%, derived from polysomnography (diagnostic or during (PAP) treatment)
Written informed consent provided
Disqualifiers
None
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
1,500 Participants
are divided into 1 treatment groupLocations
14OLV Ziekenhuis9300, Aalst Belgium
UZA2650, Antwerp Belgium
ZNA Middelheim2020, Antwerp Belgium
AZ Sint-Jan8000, Bruges Belgium
Sponsors and collaborators
Universitaire Ziekenhuizen KU Leuven
Lead sponsor
Philips Respironics
Collaborator
Source ClinicalTrials.gov